CDNA CareDx, Inc.

NEUTRAL Impact: 5/10 S-3ASR
Horizon weeks Filed Apr 28, 2026 Processed 1mo ago SEC 0001104659-26-050471
Notable filing: S-3ASR
Latest settled — T+20d
CDNA ▲ +6.54% at T+20d
NEUTRAL call ✓ call won +6.54% · α vs SPY +1.08% · entry $20.80 → $22.16
Next anchor: T+60d in 6w
Currently $22.97 · +10.43% from $20.80 entry
Entry anchored
Apr 28, 04:44 PM ET
via Databento tick
T+1d
0.00%
call 0.00% · α -1.02%
$20.80
settled 6w ago
T+5d
-0.48%
call -0.48% · α -3.59%
$20.70
settled 6w ago
T+20d
+6.54%
call +6.54% · α +1.08%
$22.16
settled 17d ago
T+60d
call — · α —
in 6w

Price Chart

Loading chart...

Executive Summary

CareDx filed an automatic shelf registration (S-3ASR) on April 28, 2026, concurrently with the announcement of its Q1 2026 earnings and the acquisition of Naveris, Inc. The shelf allows for the issuance of an indeterminate amount of common stock, preferred stock, debt securities, warrants, subscription rights, and units. No specific offering size or pricing is disclosed; registration fees are deferred under Rule 457(r). The filing provides financial flexibility to fund the Naveris acquisition and for general corporate purposes, but introduces potential future dilution.

Actionable Insight

Monitor for future prospectus supplements that will disclose actual offering size, pricing, and terms. The concurrent Naveris acquisition suggests capital may be raised to fund the deal. The shelf itself is a routine financing tool, but actual offerings could be dilutive. Watch for insider selling patterns and any subsequent 8-K filings detailing a specific offering.

Key Facts

  • Filed automatic shelf registration (S-3ASR) on April 28, 2026, concurrent with Q1 2026 earnings and Naveris acquisition announcement.
  • Registration covers an indeterminate amount of common stock, preferred stock, debt securities, warrants, subscription rights, and units.
  • Registration fees are deferred under Rule 457(r); no initial offering size or pricing is specified.
  • Proceeds, if any, will be used for working capital, general corporate purposes, and potentially to support acquisitions like Naveris.
  • The shelf provides financial flexibility but introduces potential future dilution for existing shareholders.
  • Q1 2026 results and the Naveris acquisition are detailed in concurrently filed 10-Q and 8-K, providing context for the capital need.

Financial Impact

Undisclosed; no specific offering size or pricing provided in the filing.

dilutiondebt

Risk Factors

  • Potential dilution from future equity or convertible debt offerings under the shelf.
  • Increased leverage if debt securities are issued.
  • Execution risk related to the integration of Naveris acquisition.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
60% bullish (15 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
S-3ASR Filing (Primary)0001104659-26-050471
Document: tm2612370d2_ex4-2.htm0001104659-26-050471
Document: tm2612370d1_ex-filingfees.htm0001104659-26-050471
Document: tm2612370d2_ex4-3.htm0001104659-26-050471
5 reports for CDNA
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +14.57%Feb 24, 2026
Filters
Rows
Reports for CDNA — sortable, filterable
Type Now
Jun 5, 2026
7d ago
DEFA14A
NEUTRAL ★ 2/10
$23.16 awaiting T+20awaiting T+20$22.97 (−0.82%)
Apr 28, 2026
6w ago
S-3ASR
NEUTRAL ★ 5/10
$20.80 $22.16▲ +6.54%▲ +1.08%$22.97 (+10.43%)
Apr 16, 2026
8w ago
8-K
BULLISH ★ 8/10
$22.42 $20.61▼ −8.07%▼ −13.89%$22.97 (+2.45%)
Feb 25, 2026
15w ago
8-K/A
BULLISH ★ 8/10
$18.46 $18.08▼ −2.06%▲ +3.18%$22.97 (+24.43%)
Feb 24, 2026
15w ago
8-K
BULLISH ★ 7/10
$18.46 $18.08▼ −2.06%▲ +3.18%$22.97 (+24.43%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (49h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access